
|Videos|March 17, 2016
The Effects of Expanded Naloxone Access
Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the effects of expanded naloxone access.
Advertisement
Theodore Pikoulas, PharmD, BCPP, the Associate Director of Behavioral Health Pharmacy Programs for Community Care of North Carolina, discusses the effects of expanded naloxone access.
This video was recorded at the 2016 Pharmacy Home Project Meeting in Durham, North Carolina.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
2
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
3
A Closer Look at Interdisciplinary Care with Unit-Based Pharmacy
4
Examining the Safety Profiles of SG and Pembrolizumab in ASCENT-04
5



















































































































































































































